This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Thomas A Beyer: Innovator in Tissue Damage Prevention
Introduction
Thomas A Beyer is a notable inventor based in Old Lyme, CT (US). He has made significant contributions to the field of medicine, particularly in methods aimed at reducing tissue damage associated with ischemia. With a total of 2 patents, his work has the potential to impact patient care positively.
Latest Patents
Beyer’s latest patents include a "Method of reducing tissue damage associated with non-cardiac ischemia." This method involves administering an effective amount of an aldose reductase inhibitor to prevent non-cardiac tissue damage resulting from ischemia. Another significant patent is the "Method of reducing tissue damage associated with ischemia," which focuses on administering a sorbitol dehydrogenase inhibitor to patients in need of treatment.
Career Highlights
Thomas A Beyer is currently associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to explore innovative solutions to complex medical challenges.
Collaborations
Beyer has collaborated with notable colleagues, including Delvin R Knight, Jr and Banavara L Mylari. These partnerships have likely contributed to the advancement of his research and patent developments.
Conclusion
Thomas A Beyer stands out as an inventor dedicated to improving medical outcomes through innovative methods. His patents reflect a commitment to addressing critical health issues, particularly in the realm of tissue damage prevention.